News

Antidepressants added to PCN structured medication review list

From 2025/2026, primary care networks are required to include people using antidepressants for structured medication reviews as part of medicines optimisation processes for “high-risk cohorts”.…

Published: 8 April 2025

News

Green badge scheme for pharmacies launched by RPS

The Greener Pharmacy Toolkit, commissioned by NHS England, allows pharmacies to monitor and lower their environmental impact.…

Published: 8 April 2025

News

Pharmacies achieve more than double target number of blood pressure checks, NHS England data reveal

Data published by NHS England show that in 2024/2025, community pharmacies delivered 199,182 blood pressure checks and 40,467 oral contraception consultations against a target of 71,000 and 25,800, respectively.…

Published: 7 April 2025

News

Patients in emergency departments should be supported to self-administer time-critical medicines, says royal college

Advice produced with the UK Clinical Pharmacy Association urges that emergency departments should hold self-administered time-critical medicines to the same monitoring and governance oversight standards as non self-administered medicines.…

Published: 7 April 2025

News

Scottish Pharmacy Board meeting: 28 February 2025

An overview of the latest open meeting of the Scottish Pharmacy Board.…

Published: 7 April 2025

News

English Pharmacy Board meeting: 26 February 2025

An overview of the latest open meeting of the English Pharmacy Board.…

Published: 7 April 2025

News

Welsh Pharmacy Board meeting: 21 February 2025

An overview of the latest open meeting of the Welsh Pharmacy Board.…

Published: 7 April 2025

News

NHS England increases ARRS reimbursement for pharmacists in 2025/2026

The maximum reimbursable amount for Band 7–8a pharmacists employed under the Additional Roles Reimbursement Scheme will increase to £66,972.…

Published: 4 April 2025

News

NICE approves first NHS treatment for advanced blood cancer

Brentuximab combination therapy is a first-line treatment option for previously untreated stage 3 or 4 CD30-positive Hodgkin lymphoma that could benefit up to 800 people annually.…

Published: 4 April 2025

News

NHS increases funding for inclisiran although uptake remains ‘slower than expected’

In a letter sent to colleagues, NHS England said it had increased the reimbursement fee for inclisiran from £50 to £60.…

Published: 3 April 2025